Resolution of Macular Edema secondary to rituximab after intravitreal dexamethasone: A case report and a review of the literature

Purpose to report a case of bilateral macular edema (ME) secondary to Rituximab infusions in a woman affected by IgG4-Related Disease and to review of prior cases of ME related to Rituximab. Observations ME completely resolved after Intravitreal Dexamethasone Implant (IDI). Conclusions and Importanc...

Full description

Saved in:
Bibliographic Details
Published in:European journal of ophthalmology 2024-03, Vol.34 (2), p.NP52-NP55
Main Authors: Maceroni, Martina, Minnella, Angelo Maria
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose to report a case of bilateral macular edema (ME) secondary to Rituximab infusions in a woman affected by IgG4-Related Disease and to review of prior cases of ME related to Rituximab. Observations ME completely resolved after Intravitreal Dexamethasone Implant (IDI). Conclusions and Importance ME is a rare complication after Rituximab infusions and very few cases are reported in the literature. Usually, ME occurs a few weeks after systemic administration and is probably related to a local release of cytokines. It resolves with oral, subtenon or intravitreal steroids. Our case is the first showing that IDI is a safe and effective treatment in ME secondary to Rituximab. Rituximab is not required to be discontinued if treatment for ME is started.
ISSN:1120-6721
1724-6016
DOI:10.1177/11206721231199120